What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
A recent article in the New York Times reported on the stories of a number of individuals struggling to cope with drug prices for essential medications that are far beyond what they can afford.
Dr. Elisabeth Rosenthal, in her book “An American Sickness” gives us some perspective on how we got to where we are today with healthcare costs in this country and what we can do about it. Continue reading
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this fall.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
Earlier this year I made the decision to undergo genetic testing to find out whether I’ve inherited any genetic mutation that could increase my risk for a new breast cancer diagnosis or for other cancers.
I was diagnosed with breast cancer when I was only in my mid-thirties. But that was in 1993 and, for a number of reasons, including having no family history of breast or ovarian cancer, I’ve never had genetic testing before.
Here’s what the experience was like for me and some of the helpful things I learned in the process. Continue reading
Every two years, the American Cancer Society publishes a new report on breast cancer trends. The latest report came out earlier this month.
Does the report show we’re really making a great deal of progress against breast cancer as some of the media stories are presenting it? Or is progress more incremental in nature?
And how might we respond in a way that could make a difference–during this month of October and during the rest of the year as well?
What’s the latest news in cancer research that stands out the most? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this summer.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
In this post, I’m taking up a summer blogging challenge posed by Nancy at Nancy’s Point to answer ten random questions about cancer that she has put together.
Nancy has shared her answers to the ten questions, and asked other bloggers and readers to join in and answer as many as they like.
So, here are my answers to Nancy’s ten random questions about cancer. Continue reading
Like many of us, I’ve long felt that one of the best ways to help in the fight against cancer is by making a donation to a charity that conducts or funds cancer research.
This post is the fourth in a series in which we’re taking a look at high quality charities that support cancer research as their main focus. In this post, we’ll review the Cancer Research Institute, including its mission and approach, history, notable financial facts and results reporting. Continue reading
Back in August 2015, I wrote about an article in the journal Nature on some interesting new discoveries about the role of the hormone progesterone in hormone receptor-positive breast cancer
The research suggested that adding progesterone to standard treatment with tamoxifen or an aromatase inhibitor could increase the effectiveness of treatment for this subtype of breast cancer, while possibly also lowering toxicity.
Those findings are now going to be investigated in three clinical trials, according to a recent report by Cancer Research UK. Continue reading
